Evidence and Diabetes Technology: A Catch-22?

Diabetes technology is a dynamically evolving field. Sometimes the pace of evaluation of new diabetes technologies does not keep pace with its dynamic development. This leads to a dilemma: either the evaluation lags behind the developing technologies or diabetes technologies are used without sufficient evaluation. This situation is known as the Catch 22 dilemma. The aim of this paper is a discussion of ideas for a timely assessment, taking account of the speed of technological development and the need for evidence and safety improvement.

Automated summary

Diabetes technology is a rapidly evolving field, but the evaluation of new technologies often lags behind. This Catch 22 dilemma presents a challenge: either the evaluation falls behind or technologies are used without proper assessment. This paper aims to discuss ideas for timely assessment that considers the pace of technological development and the need for evidence and safety improvement.